Sterne Agee Expects Allergan to Resist Hostile Takeover by Valeant
April 22, 2014 at 09:30 AM EDT
In a report published Tuesday, Sterne Agee analyst Shibani Malhotra reiterated a Buy rating and $142.00 price target on Allergan (NYSE: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.